Authors



Colin D. Rehm, PhD

Latest:

Medicare Underpayment for Diabetes Prevention Program: Implications for DPP Suppliers

The actual costs of implementing the evidence-based Diabetes Prevention Program (DPP) were compared with the latest reimbursement rates provided by CMS.


Shimon Blackman, BS (Pharm)

Latest:

Prior Authorization to Improve Testing of Glycosylated Hemoglobin in a Managed Care Setting

Prior authorization was successfully implemented in a managed care setting to obtain 100.0% performance of A1C testing in patients with diabetes treated with expensive drugs.




Richard Beaser, MD

Latest:

CHAPTER 5. Clinical Guideline for Pharmacological Management of Adults With Type 2 Diabetes

From the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018. For the Figure and Tables, download the PDF at the end of the chapter.


Azam Sabahi, BS

Latest:

Patients' Preferences for Receiving Laboratory Test Results

The main reason given for receiving results online was time savings, reported by 77% of participants, followed by lowering the chance of missing the results (31%).


Rachel Jawahar, PhD, MPH

Latest:

Fragmented Ambulatory Care and Subsequent Emergency Department Visits and Hospital Admissions Among Medicaid Beneficiaries

Among Medicaid beneficiaries, having more fragmented ambulatory care was associated with a modest independent increase in the hazard of a subsequent emergency department visit.



Miranda Laurant, PhD

Latest:

Shifting Cardiovascular Care to Nurses Results in Structured Chronic Care

This study sought to explore if shifting care to nurses in cardiovascular risk management in primary care is a key to more structured chronic care.


Jie Zhang, PhD

Latest:

The Potential Impact of CAR T-Cell Treatment Delays on Society

Treatment delays limit the social value generated by chimeric antigen receptor (CAR) T-cell therapy for the treatment of pediatric acute lymphoblastic leukemia and diffuse large B-cell lymphoma.


LeRoi S. Hicks, MD, MPH

Latest:

Low-Cost Insulin for Socially At-Risk Patients: Evidence for Effectiveness

Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.


Caitlin Lupton, MSc

Latest:

Cost Burden of Hepatitis C Virus Treatment in Commercially Insured Patients

Rates of hepatitis C virus (HCV) treatment in a commercially insured population doubled after availability of new direct-acting antivirals. Member out-of-pocket spending was kept low while the health plan bore 99% of spending on HCV medications.



Julia C. Prentice, PhD

Latest:

Call Center Performance Affects Patient Perceptions of Access and Satisfaction

Greater telephone wait times, but not abandonment rates, were associated with lower patient perceptions of their ability to obtain urgent care in a timely manner.



Susannah Fox, BA

Latest:

Bowling Alone, Healing Together: The Role of Social Capital in Delivery Reform

As delivery reform unfolds and leads to new models of care delivery, social capital will be a powerful concept to incorporate into their design and evaluation.


Jinkyung Ha, PhD

Latest:

Diabetes Care Improvement in Pharmacist- Versus Nurse-Supported Patient-Centered Medical Homes

In this longitudinal comparative effectiveness study of different chronic disease self-management support approaches within 1 system, both pharmacist- and nurse-led patient-centered medical home approaches improved diabetes care.


Lori A. Bastian, MD

Latest:

Association Between Length of Stay and Readmission for COPD

Among patients admitted for chronic obstructive pulmonary disease (COPD) at Veterans Affairs hospitals, hospital-level length of stay was not associated with 30-day readmission.


Anjali Dixit, MD

Latest:

Medicare Savings From Conservative Management of Low Back Pain

This instrumental variables analysis estimates that Medicare would realize $362 million in annual savings if all patients with newly diagnosed low back pain were managed conservatively.


Russel T. Burge, PhD

Latest:

Therapies for Treatment of Osteoporosis in US Women: Cost-effectiveness and Budget Impact Considerations

Osteoporosis treatment for high-risk women is cost-effective, with bisphosphonates providing the most benefit at the lowest cost.




Mary Kruczynski

Latest:

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.


Vikram Khanna, MHS

Latest:

Employers Should Disband Employee Weight Control Programs

No corporate weight control program has ever reported savings or even sustained weight loss using valid metrics across a sizable population for 2 years or more, accounting for dropouts and nonparticipants. Further, these programs can harm morale and even the health of the employees themselves.



Paul F. Simonelli, MD, PhD

Latest:

Impact of Primary and Specialty Care Integration via Asynchronous Communication

Geisinger’s Ask-a-Doc program, which enables direct asynchronous communication between primary and specialty care, was associated with lower healthcare utilization and cost, implying more efficient care.



Ilia L. Ferrusi, PhD

Latest:

Closing the Personalized Medicine Information Gap: HER2 Test Documentation Practice

Despite universal access to HER2 testing in Ontario, variability in reporting by region and disease severity presents challenges for program evaluation and quality improvement initiatives.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo